港股异动 | 医脉通(02192)尾盘涨逾27% 公司为在线专业医师平台 此前推出AI医生MedliveGPT

智通财经
14 Feb

国证国际指出,在国内,DeepSeek凭借开源、低成本、高性能等优势,正在掀起人工智能的新浪潮。在海外,Cathie Wood创立的 ARK Invest近日发布《Big Ideas 2025》,报告指出,未来人工智能在医疗保健领域将影响深远。在全球AI技术快速发展的背景下,AI医疗或成为今年医药行业的核心主线之一。

国金证券指出,医脉通是国内领先的在线专业医师平台,已接入DeepSeek加速AI商业化落地。根据公司财报,截至1H24,医脉通平台有400万+注册医师,占中国执业医师的88%,有700万注册用户,250万月活跃用户,598万次付费点击,同比增长40%。医脉通主营业务包括精准营销及企业解决方案,医学知识服务,智能患者管理服务。公司持续投入研发,推出国内首个大模型驱动的AI医生MedliveGPT(医脉通大模型),已通过国家网信办大模型算法备案。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10